B2B Infrastructures in the Process of Drug Discovery and Healthcare

B2B Infrastructures in the Process of Drug Discovery and Healthcare

In this paper we describe a demonstration of an innovative B2B infrastructure which can be used to support collaborations in the pharmaceutical industry to achieve the drug discovery goal. Based on experience gained in a wide range of collaborative projects in the areas of grid technology, semantics...

Full description

Bibliographic Details
Main Authors: Radetzki, U. (Author), Boniface, M.J (Author), Walland, Paul. W. (Author)
Format: Article
Language:English
Published: 2007.
Subjects:
Article
Online Access:Get fulltext
LEADER 00912 am a22001453u 4500
001 268550
042 |a dc 
100 1 0 |a Radetzki, U.  |e author 
700 1 0 |a Boniface, M.J.  |e author 
700 1 0 |a Walland, Paul. W.  |e author 
245 0 0 |a B2B Infrastructures in the Process of Drug Discovery and Healthcare 
260 |c 2007. 
856 |z Get fulltext  |u https://eprints.soton.ac.uk/268550/1/2007_-_18550.pdf 
520 |a In this paper we describe a demonstration of an innovative B2B infrastructure which can be used to support collaborations in the pharmaceutical industry to achieve the drug discovery goal. Based on experience gained in a wide range of collaborative projects in the areas of grid technology, semantics and data management we show future work and new topics in B2B infrastructures which arise when considering the use of patient records in the process of drug discovery and in healthcare applications. 
655 7 |a Article 

Similar Items